Matinas BioPharma Inc. (MTNB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Matinas BioPharma Inc.

    AMEX: MTNB · Real-Time Price · USD
    1.90
    -0.04 (-2.06%)
    At close: Oct 06, 2025, 3:59 PM
    1.94
    2.00%
    After-hours: Oct 06, 2025, 05:59 PM EDT

    Matinas BioPharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.1 -2.05 -8.33 -10.03
    PEG Ratio
    		 0.02 -0.03 0.21 2.76
    PS Ratio
    		 n/a 42.86 34.00 6.37K
    PB Ratio
    		 0.33 2.44 2.96 4.04
    P/FCF Ratio
    		 -0.16 -3.03 -5.41 -13.71
    P/OCF Ratio
    		 -0.16 -3.07 -5.66 -13.94
    OCF/S Ratio
    		 n/a -13.94 -6.01 -456.71
    Debt / Equity Ratio
    		 0.38 0.18 0.11 0.09
    Quick Ratio
    		 3.01 5.93 8.06 11.73
    Current Ratio
    		 3.01 5.93 8.06 11.73
    Asset Turnover
    		 n/a 0.04 0.07 0.00
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -3.2 -1.19 -0.36 -0.4
    Return on Assets
    		 -1.92 -0.91 -0.29 -0.35
    Return on Invested Capital
    		 -1.75 -1.03 -0.37 -0.39
    Dividend Yield
    		 n/a n/a n/a 3.97
    Payout Ratio
    		 n/a n/a n/a -39.84
    Gross Profit Margin
    		 n/a -12.22 -4.23 -22.44
    Net Profit Margin
    		 n/a -20.93 -4.08 -635.21
    Pretax Profit Margin
    		 n/a -20.93 -6.59 -698.51
    Operating Profit Margin
    		 n/a -21.68 -7.71 -742.05
    FCF Margin
    		 n/a -14.14 -6.29 -464.52
    EBITDA Margin
    		 n/a -20.83 -7.6 -733.66

    Add to Watchlist